Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Mabs
|
December 29, 2017
Structural insights into humanization of anti-tissue factor antibody 10H10
Alexey Teplyakov, Galina Obmolova, Thomas J Malia, et al.
Journal of Molecular Biology
|
March 16, 2010
Human framework adaptation of a mouse anti-human IL-13 antibody
Johan Fransson, Alexey Teplyakov, Gopalan Raghunathan, et al.
NPJ Genomic Medicine
|
April 15, 2020
<i>ATP7B</i> variant c.1934T > G p.Met645Arg causes Wilson disease by promoting exon 6 skipping
Daniele Merico, Carl Spickett, Matthew O'Hara, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 22, 2019
Structure-guided design fine-tunes pharmacokinetics, tolerability, and antitumor profile of multispecific frizzled antibodies
Swetha Raman, Melissa Beilschmidt, Minh To, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 28, 2022
Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment
Robin M Hallett, Ester Bonfill-Teixidor, Raffaella Iurlaro, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Mabs
|
December 29, 2017
Structural insights into humanization of anti-tissue factor antibody 10H10
Alexey Teplyakov, Galina Obmolova, Thomas J Malia, et al.
Journal of Molecular Biology
|
March 16, 2010
Human framework adaptation of a mouse anti-human IL-13 antibody
Johan Fransson, Alexey Teplyakov, Gopalan Raghunathan, et al.
NPJ Genomic Medicine
|
April 15, 2020
<i>ATP7B</i> variant c.1934T > G p.Met645Arg causes Wilson disease by promoting exon 6 skipping
Daniele Merico, Carl Spickett, Matthew O'Hara, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 22, 2019
Structure-guided design fine-tunes pharmacokinetics, tolerability, and antitumor profile of multispecific frizzled antibodies
Swetha Raman, Melissa Beilschmidt, Minh To, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 28, 2022
Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment
Robin M Hallett, Ester Bonfill-Teixidor, Raffaella Iurlaro, et al.
Page
of 2